Long-Term Assets: The sum of all assets classified as non-current.
Sunshine Biopharma, Inc. (SBFM) had Long-Term Assets of $4.59M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$34.87M |
|
$-5.13M |
|
$24.20M |
|
$10.67M |
|
$40.69M |
|
$-5.81M |
|
$0.44M |
|
$-5.37M |
|
$-5.37M |
|
$-5.13M |
|
$-5.13M |
|
$-5.13M |
|
$-5.13M |
|
$-5.81M |
|
$-5.59M |
|
0.70M |
|
0.70M |
|
$-7.32 |
|
$-7.32 |
|
| Balance Sheet Financials | |
$25.97M |
|
$0.55M |
|
|
Long-Term Assets |
$4.59M |
$30.56M |
|
$6.31M |
|
-- |
|
$0.74M |
|
$7.06M |
|
$23.49M |
|
$20.48M |
|
$23.50M |
|
2.58M |
|
| Cash Flow Statement Financials | |
$-12.53M |
|
$-2.32M |
|
$9.29M |
|
$16.29M |
|
$9.69M |
|
$-6.61M |
|
$0.01M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.11 |
|
-- |
|
-- |
|
-- |
|
-- |
|
30.59% |
|
-16.67% |
|
-16.67% |
|
-16.02% |
|
-15.40% |
|
-14.72% |
|
$-14.19M |
|
-- |
|
-- |
|
-- |
|
1.14 |
|
2.15 |
|
9.02 |
|
40.49 |
|
-21.86% |
|
-25.07% |
|
-16.80% |
|
-21.85% |
|
$9.11 |
|
$-20.22 |
|
$-17.86 |
|